Biodesix raises 2026 revenue outlook to $108M-$114M as it targets sustained adjusted EBITDA profitability (NASDAQ:BDSX)
Earnings Name Insights: Biodesix (BDSX) Q1 2026 Administration view Scott Hutton (President, CEO & Director) described Q1 as “an distinctive ...



.webp?rect=92%2C0%2C1733%2C910&w=1200&auto=format%2Ccompress&ogImage=true&w=350&resize=350,250&ssl=1)




